on Drug Registration

Circular No. 02/2018/TT-BYT guiding some articles of Decree No. 54

Understanding these regulations is vital, as they outline the pathway for drug registration, including requirements for market authorization renewal. As a Vietnam DAV drug registration consultant, it is critical to stay updated on any amendments or updates to these regulations, ensuring compliance throughout the renewal process.

Step 2: Preparing Documentation for Marketing Authorization Renewal

The next step involves gathering and preparing the required documentation necessary for the marketing authorization renewal application. Companies should ensure that their submissions are thorough and adhere to the specific requirements set by the DAV.

Generally, the documentation package must include:

• Application Form: A completed application form for marketing authorization renewal.
• Product Information: Updated summary of product characteristics (SmPC), including indications, contraindications, and side effects.
• Quality Data: Recent data demonstrating the product’s quality, safety, and efficacy, including stability data and manufacturing processes.
• Pharmacovigilance Reports: Updated reports on adverse drug reactions (ADRs) that may have occurred since the last renewal.
• Labeling and Packaging: Samples of the product’s labeling and packaging to ensure compliance with local regulations.
• Market Availability: Evidence of continuous market presence in Vietnam and any other countries where the product is marketed.

It is advisable to work closely with a Vietnam DAV drug registration consultant to ensure that all documentation complies with the required standards, as incomplete or inaccurate submissions can lead to delays or rejections.

Step 3: Submitting the Renewal Application

Once the documentation is prepared, the next step is to submit the renewal application to the DAV. The submission can be done online through the MoH’s online portal or in person at the DAV office. Each submission must be accompanied by the requisite fees as outlined in the current fee schedule.

Upon submission, a unique application reference number will be assigned, which can be used to track the progress of the application. It is crucial to maintain a record of this reference number for all future communications with the DAV.

Following submission, companies should closely monitor the application status. The DAV typically provides a preliminary review within a stipulated timeframe, and companies may be required to provide additional information or clarification if requested.

For effective tracking, companies can regularly consult the official MoH website for updates on their application status and any potential changes in the regulatory environment that may affect their submission.

Step 4: Review Process by the Drug Administration of Vietnam

The DAV undertakes a comprehensive review of the submitted application materials. The review process involves various scientific evaluations focusing on the quality, safety, and efficacy of the pharmaceutical product. This typically includes:

• Assessment of documentation for completeness and accuracy.
• Evaluation of quality data, including active ingredients and manufacturing processes.
• Examination of pharmacovigilance data, ensuring that the product’s risk-benefit profile remains favorable.
• Checking updates and compliance with labeling regulations.

During this phase, the DAV may issue queries relating to the application. Companies should be prepared to respond promptly with detailed explanations or additional documentation. Collaboration with a Vietnam DAV drug registration consultant can facilitate timely responses and ensure that the application meets all regulatory expectations.

The timeline for this review can fluctuate based on the application’s complexity; therefore, maintaining communication with the DAV can help manage expectations regarding the duration of the review process.

Step 5: Receiving the Outcome of the Review

After the review process is completed, the DAV will render a decision on the marketing authorization renewal application. The outcome may include:

• Approval of the renewal, allowing the product to remain on the market.
• Conditional approval with additional commitments or monitoring requirements.
• Rejection of the application, with specific reasons outlined.

If approved, the renewal will typically be valid for five years, during which the pharmaceutical company must adhere to reporting obligations and pharmacovigilance requirements as mandated by the DAV. Compliance with these commitments is essential for maintaining market access within Vietnam.

In the case of a rejection, companies should closely review the feedback provided by the DAV and determine whether to address the identified deficiencies or consider reapplying after further preparation.

Step 6: Post-Approval Commitments and Compliance

Upon receiving the renewal of marketing authorization, companies incur post-approval obligations that must be diligently followed. These may include:

• Regular reporting of any changes in product information, including formulation changes, clinical indications, or adverse events.
• Conducting post-marketing surveillance to ensure continued safety and efficacy of the product within the market.
• Adhering to all pharmacovigilance norms set by the DAV, with timely reporting of any adverse reactions.

Failing to meet these obligations may lead to sanctions by the DAV, including potential suspension or revocation of marketing authorization. Companies should develop robust regulatory compliance programs to monitor ongoing obligations effectively. Keeping a thorough record of all communications with the DAV and documenting compliance activities is also advisable, ensuring readiness for any inspections or audits.

Conclusion

Marketing authorization renewal in Vietnam entails a systematic approach grounded in compliance with national regulations. By following the outlined steps — understanding the regulatory framework, preparing thorough documentation, submitting applications, engaging in the review process, and adhering to post-approval commitments — pharmaceutical companies can effectively navigate the complexities of the renewal landscape.

Engaging a reputable Vietnam DAV drug registration consultant may be instrumental in enhancing the efficiency of the process and ensuring regulatory compliance. By remaining vigilant and proactive, companies can secure their place in the competitive Vietnamese pharmaceutical market and uphold patient safety and product integrity.